Overview
Services

Japan Hospice Holdings Inc.

Japan Hospice Holdings operates hospice residential facilities and home-based hospice services exclusively for terminal cancer patients and intractable disease patients in Japan, under the mission of 'research and promotion of home hospice care.' Its core offering, the hospice housing business (over 90% of revenue), provides rental housing co-located with visiting nursing and home care offices staffed 24/7 by nurses and caregivers delivering palliative and terminal care. The company also provides visiting nursing services and integrated home care services combining day, overnight, and home-visit care, operating within Japan's regional comprehensive care system.

Market Cap
¥3.87B
US$24.6M
EV
¥15.0B
US$95.6M
Stock¥456▼-0.65%
US$1 = ¥157.05 (2026-10-22)
LTM EV/EBITDA
9.1
x
LTM EV/EBIT
13.7
x
LTM PER
11.7
x
LTM PBR
1.1
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-89.6%pt
10012
Oct 23, 25 – Oct 23, 26StockTOPIX
1Feb 16, 26Disappointment selling after Q3 earnings
2Aug 17, 26Q2 FY2026/12 earnings announced
MC → EV Bridge
3.87BUS$24.6MMarket Cap13.1BUS$83.3M+ Debt1.93BUS$12.3M− Cash0.00BUS$0.00M− Inv. Sec.15.0BUS$95.6MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
6.02US$38.3M'21/127.89US$50.3M'22/129.87US$62.9M'23/1212.1US$77.1M'24/1214.2US$90.2M'25/12
EBITDA 5Y (¥B)
0.77US$4.91M'21/121.24US$7.87M'22/121.63US$10.4M'23/121.76US$11.2M'24/121.37US$8.73M'25/12
Net Income 5Y (¥B)
0.24US$1.53M'21/120.45US$2.89M'22/120.68US$4.34M'23/120.64US$4.07M'24/120.28US$1.77M'25/12
Capital Structure
22%
78%
EquityD/E 3.57xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
1.04US$6.59M6.67US$42.5M'21/121.51US$9.61M8.09US$51.5M'22/121.88US$12.0M10.9US$69.4M'23/121.53US$9.72M13.2US$84.0M'24/122.01US$12.8M13.2US$83.9M'25/12
Shareholders
Top 10 hold 45.8%
1
SUGI HOLDINGS Co.,LTD.
18.86%
2
BBH CO FOR ARCUS JAPAN VALUE FUND (Standing Proxy: MUFG Bank, Ltd.)
4.05%
3
Tadashi TAKAHASHI
3.55%
4
Daiwa Securities Co. Ltd.
3.16%
5
BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC; Standing Proxy: MUFG Bank, Ltd.)
3.00%
6
Shigetaka MIURA
2.97%
7
Yoshiaki OTA
2.91%
8
Shinichiro KATO
2.84%
9
Morgan Stanley MUFG Securities Co., Ltd.
2.43%
10
Rakuten Securities, Inc. (Joint Account)
2.00%
Management
8 officers
Tadashi TAKAHASHI
Representative Director, President and CEO
Apr 1984 Joined Sanyado Kobo Aug 1987 Joined Sakakura Architects Institute May 1991 Director, Manifield Co., Ltd. Aug 1991 Joined Maruyama Construction Co., Ltd. Oct 1996 Director, Rounds Co., Ltd. Aug 2008 Representative Director, Yumi Care Co., Ltd. Dec 2011 Representative Director, On & On Co., Ltd. (now Family Hospice Co., Ltd.) Aug 2014 Representative Director, Nurse Call Co., Ltd. (now Family Hospice Co., Ltd.) Jan 2017 Representative Director, President of the Company Apr 2024 Representative Director, President and CEO of the Company (current)
1962-01-21
Shinichiro KATO
Director, Vice President and CFO
Oct 1998 Joined Ota Showa & Co. (now EY ShinNihon LLC) Apr 2002 Registered as Certified Public Accountant Apr 2006 CEO, Avantec Vascular Corp. Apr 2010 Joined Goodman Co., Ltd. as Executive Officer Jul 2013 CFO, Reed Exhibitions Japan Ltd. Sep 2015 Joined Nurse Call Co., Ltd. (now Family Hospice Co., Ltd.) as Executive Officer, General Manager of Administration Division Mar 2016 Director and Managing Executive Officer, General Manager of Administration Division, Nurse Call Co., Ltd. (now Family Hospice Co., Ltd.) Jan 2017 Managing Director, General Manager of Administration Division of the Company Apr 2024 Director, Vice President and CFO of the Company (current)
1974-09-24
Takashi HAYASHI
Audit & Supervisory Board Member
Oct 1991 Joined Chuo Shinko Audit Corporation Jan 1997 Joined JAFCO Group Co., Ltd. Mar 2005 Opened Hayashi CPA Office; Representative Partner (current) Jun 2013 Audit & Supervisory Board Member, Nippon Sanyo Industry Co., Ltd. Jun 2016 Director (Audit and Supervisory Committee Member), Nippon Sanyo Industry Co., Ltd. Jan 2017 Audit & Supervisory Board Member of the Company (current) Oct 2018 Director, Kips Co., Ltd. (current) Apr 2020 Representative Partner, Gratia Tax Accountants Corporation Jun 2020 Outside Director, Nihon Plast Co., Ltd. (current)
1966-10-27
Keiko TAMURA
Director
Apr 1978 Joined Horii Gastroenterology Hospital Apr 1984 Joined Ishizuka Hospital Mar 1987 Joined Nursing Department, Yodogawa Christian Hospital (operated by Presbyterian Mission in Japan, Religious Corporation) Jan 2014 Professor, Graduate School of Medicine, Kyoto University Apr 2020 Director of the Company (current) Apr 2023 Full-time Professor, Research and Development Promotion Center for Commercialization, Medical Innovation Research Organization, Osaka Dental University Apr 2025 Room Head and Specially Appointed Professor, Development Preparation Office, Graduate School of Nursing, Osaka Dental University (current)
1957-09-05
Takayuki TOMITA
Director
Apr 1979 Joined Chuyaku Co., Ltd. Sep 1987 Joined Arpas Co., Ltd. (now Cocokara fine Healthcare Co., Ltd.) Dec 1998 Joined Yamamoto Pharmacy Co., Ltd. (now Cocokara fine Healthcare Co., Ltd.) Jan 2002 Representative Director, President, Seeds & Arpas Co., Ltd. (now Cocokara fine Healthcare Co., Ltd.) May 2004 Executive Officer, General Manager of Sales Support Department, Zip Holdings Co., Ltd. (now Cocokara fine Healthcare Co., Ltd.) Oct 2010 Director, General Manager of Store Operations Division, Zip Drug Co., Ltd. (now Cocokara fine Healthcare Co., Ltd.), concurrently Executive Officer, Cocokara fine Co., Ltd. Apr 2012 Representative Director, President, Zip Drug Co., Ltd., concurrently Executive Officer, Cocokara fine Co., Ltd. Jun 2012 Representative Director, President, Zip Drug Co., Ltd., concurrently Senior Executive Officer, Cocokara fine Co., Ltd. Apr 2013 Director, General Manager of Suburban Drugstore Business Division, Cocokara fine Healthcare Co., Ltd. Apr 2014 Senior Executive Officer, Kinki Area General Manager, Drug Business Division, Cocokara fine Healthcare Co., Ltd. Apr 2015 Director, Western Japan Supervisor, Drug Business Division, Cocokara fine Healthcare Co., Ltd. Apr 2016 Managing Director, General Manager of Drug Business Division, Cocokara fine Healthcare Co., Ltd. Apr 2018 Managing Director, in charge of overall Drug and Pharmacy Business, Cocokara fine Healthcare Co., Ltd. Jun 2018 Managing Director, in charge of Business Administration, Cocokara fine Healthcare Co., Ltd. Jun 2019 Director and Managing Executive Officer, in charge of Sales, Cocokara fine Co., Ltd. Aug 2020 Joined Sugi Pharmacy Co., Ltd. Mar 2021 Deputy General Manager, Store Development Division, Sugi Pharmacy Co., Ltd. Mar 2024 Director of the Company (current) Mar 2025 Terminal Care Promotion Project Leader, Sugi Holdings Co., Ltd. (current)
1957-01-15
Mitsuhide SUGITA
Director
Apr 1982 Joined Shizuoka Bank, Ltd. Jun 2011 Executive Officer, Numazu Block Head Branch Manager and Numazu Branch Manager, Shizuoka Bank, Ltd. Jun 2013 Executive Officer, Hamamatsu Block Head Branch Manager and Hamamatsu Sales Department General Manager, Shizuoka Bank, Ltd. Jun 2015 Managing Executive Officer, Western Company President, Shizuoka Bank, Ltd. Apr 2019 Senior Managing Executive Officer, Metropolitan Area Company President, Shizuoka Bank, Ltd. Jun 2023 Outside Director (Audit and Supervisory Committee Member), Suzuyo Shinwart Co., Ltd. (current) Mar 2026 Director of the Company (current)
1957-09-29
Masahiro KAWAGUCHI
Full-time Audit & Supervisory Board Member
Apr 1982 Joined Sohgo Security Services Co., Ltd. (now ALSOK Co., Ltd.) Jun 2011 Executive Officer, in charge of Development Planning; General Manager, Development Planning Department, ALSOK Co., Ltd. Apr 2014 Managing Executive Officer, General Supervisor of Development and Technology, ALSOK Co., Ltd. Apr 2017 Representative Director, President, Nihon Facilio Co., Ltd. Apr 2022 Director and Vice President, Espitome Co., Ltd. Nov 2023 Representative Director, M&K Consulting Co., Ltd. (current) Mar 2026 Full-time Audit & Supervisory Board Member of the Company (current)
1959-10-22
Yumi KATO
Audit & Supervisory Board Member
Apr 1997 Joined Eurasia Travel Co., Ltd. May 2000 Joined Tempstaff Co., Ltd. Aug 2010 Registered as Attorney-at-Law; joined Allegretto Law Office Mar 2018 Audit & Supervisory Board Member of the Company (current) Jan 2022 Opened Ichigaya Hachiman Law Office; Representative Partner (current)
1975-03-13
Large Shareholding Reports
Arcus Investment Limited
2026-09-25
5.04%→6.09%
Arcus Investment Limited
2026-08-31
5.04%
Arcus Investment Limited
2026-08-31
5.04%→5.04%
Daiwa Asset Management Co., Ltd.
2025-10-21
5.61%→4.53%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-09-25
Large Shareholding Report
EDINET
2026-08-31
Large Shareholding Report
EDINETAmended
2026-08-31
Change Report
TDnet
2026-08-14
Q2 Earnings Flash
FY ending Dec 2026
EDINET
2026-08-14
Semi-Annual Securities Report
Period: Jan 2026 – Dec 2026
TDnet
2026-05-15
Q1 Earnings Flash
FY ending Dec 2026
EDINET
2026-03-25
Annual Securities Report
Period: Jan 2025 – Dec 2025
TDnet
2025-11-14
Q3 Earnings Flash
FY ending Dec 2025
EDINET
2025-10-21
Large Shareholding Report
EDINET
2025-08-13
Semi-Annual Securities Report
Period: Jan 2025 – Dec 2025
TDnet
2025-05-09
Q1 Earnings Flash
FY ending Dec 2025
EDINET
2025-03-27
Annual Securities Report
Period: Jan 2024 – Dec 2024
EDINET
2024-08-13
Semi-Annual Securities Report
Period: Jan 2024 – Dec 2024
EDINET
2024-05-10
Quarterly Securities Report
Period: Jan 2024 – Mar 2024
EDINET
2024-03-27
Annual Securities Report
Period: Jan 2023 – Dec 2023
EDINET
2023-11-10
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-10
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-05-12
Quarterly Securities Report
Period: Jan 2023 – Mar 2023
EDINET
2023-03-28
Annual Securities Report
Period: Jan 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-08-12
Quarterly Securities Report
EDINET
2022-05-13
Quarterly Securities Report
EDINET
2022-03-25
Annual Securities Report
EDINET
2021-11-12
Quarterly Securities Report
EDINET
2021-08-13
Quarterly Securities Report
EDINET
2021-05-14
Quarterly Securities Report
EDINET
2021-03-26
Annual Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →